A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology

PURPOSE: While the Trastuzumab for Gastric Cancer (ToGA) trial demonstrated the efficacy and safety of trastuzumab-based chemotherapy in HER2-positive metastatic gastric cancer, the overall survival (OS) benefit was not found in Asian and diffuse-type cancer patients. The aim of the study is to inve...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Res Treat
Auteurs principaux: Yi, Jun Ho, Kang, Jung Hun, Hwang, In Gyu, Ahn, Hee Kyung, Baek, Hyun Jin, Lee, Soon Il, Lim, Do Hyoung, Won, Young-Woong, Ji, Jun Ho, Kim, Hyo Song, Rha, Sun Young, Oh, Sung Yong, Lee, Kyung Eun, Lim, Taekyu, Maeng, Chi Hoon, Kim, Moon Jin, Kim, Seung Tae, Lee, Jeeyun, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Park, Se Hoon
Format: Artigo
Langue:Inglês
Publié: Korean Cancer Association 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843742/
https://ncbi.nlm.nih.gov/pubmed/26323641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2015.155
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires